Cover image of the article: Recent Advances in the Development of the Nanostructured Lipid Carriers for the Topical Fungal Infections

Image Credit:J Rep Pharm Sci

Recent Advances in the Development of the Nanostructured Lipid Carriers for the Topical Fungal Infections

Authors

Amandeep -1, Shailendra Bhatt1, Manish Kumar1,*, Sheetal Devi1, Prabhat Kumar Upadhyay2, Vipin Saini3, Amit Mittal3, Navneet Mehan1, Anupam Saini1
1Department of Pharmaceutical Chemistry, Institute of Pharmaceutical Research, GLA University, Mathura-281406, Uttar Pradesh, India
2Department of Pharmaceutics, M.M College of Pharmacy, Maharishi Mardandeshwar (Deemed to be University), Mullana, Ambala, Haryana, India
3Department of Medical Sciences, M. M. University, Solan, Himachal Pradesh, India
*Corresponding Author: Corresponding author: Department of Pharmaceutics, M. M. College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala 133207, Haryana, India. Email:manish_singh17@rediffmail.com

Journal of Reports in Pharmaceutical Sciences:Vol. 9, issue 2; 271-8
Published online:Oct 07, 2020
Article type:Systematic Review
Received:Sep 17, 2019
Accepted:Nov 09, 2019
How to Cite:- A, Bhatt S, Kumar M, Devi S, Upadhyay PK, et al. Recent Advances in the Development of the Nanostructured Lipid Carriers for the Topical Fungal Infections. J Rep Pharm Sci. 2020;9(2):e147122. doi: https://doi.org/10.4103/jrptps.JRPTPS_99_19

Abstract

Topical fungal infections are one of the often faced diseases worldwide. The first choice for the treatment of fungal infection is topical therapy due to its advantages such as decreasing the risk of systemic side effects and targeting the drug at the site of fungal infection. The treatment of the fungal infection depends on the penetration of the drug molecules through the outermost layer of the skin (stratum corneum) at an effective concentration. The disadvantages of topical treatment are its lack of drug adherence at the site of application and bigger particle size of drug molecules. Nanostructured lipid carriers are the advanced form of lipid nanoparticles and carry the nano range of the drug molecules, which helps to achieve localized and slow release. The topical route is generally preferred due to the possible side effects of oral medication. Advances in the field of formulation may soon render outdated conventional products such as creams, ointments, and gels. Several carrier systems loaded with antifungal drugs have shown promising results in the treatment of skin fungal infections. 

Highlights

Copyright

© 2020, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

15
May
2018
In vitro Evaluation of the Effects of Fluconazole and Nano-Fluconazole on Aspergillus flavus and A. fumigatus Isolates

In vitro Evaluation of the Effects of Fluconazole and Nano-Fluconazole on Aspergillus flavus and A. fumigatus Isolates

Mohammad Reza Sarrafha,
Seyed Jamal Hashemi,
Sasan Rezaei,
Mansour Bayat

Sarrafha MR, Hashemi SJ, Rezaei S, Bayat M. In vitro Evaluation of the Effects of Fluconazole and Nano-Fluconazole on Aspergillus flavus and A. fumigatus Isolates. Jundishapur J Microbiol. 2018;11(6):e57875. doi: https://doi.org/10.5812/jjm.57875

1
Feb
2025
Piperine and Lavender Oil Enriched Nanostructured Lipid Carriers to Inhibit Staphylococcus aureus Biofilm

Piperine and Lavender Oil Enriched Nanostructured Lipid Carriers to Inhibit Staphylococcus aureus Biofilm

Omolbanin Shahraki,
Maryam Sadat Nabavinia,
Abdolmotaleb Tiba,
Sara Daneshmand

Shahraki O, Nabavinia MS, Tiba A, Daneshmand S. Piperine and Lavender Oil Enriched Nanostructured Lipid Carriers to Inhibit Staphylococcus aureus Biofilm. Jundishapur J Nat Pharm Prod. 2025;20(1):e156837. doi: https://doi.org/10.5812/jjnpp-156837

15
Apr
2015
Comparison of Difference Between Fluconazole and Silver Nanoparticles in Antimicrobial Effect on Fluconazole-Resistant Candida Albicans Strains

Comparison of Difference Between Fluconazole and Silver Nanoparticles in Antimicrobial Effect on Fluconazole-Resistant Candida Albicans Strains

Shadi Alimehr,
Hamide Shekari Ebrahim Abad,
Ahmadreza Shahverdi,
Jamal Hashemi,
Kamyar Zomorodian,
Maryam Moazeni
,et al.

Alimehr S, Shekari Ebrahim Abad H, Shahverdi A, Hashemi J, Zomorodian K, et al. Comparison of Difference Between Fluconazole and Silver Nanoparticles in Antimicrobial Effect on Fluconazole-Resistant Candida Albicans Strains. Arch Pediatr Infect Dis. 2015;3(2):e21481. doi: https://doi.org/10.5812/pedinfect.21481

24
Sep
2017
What Is the Most Recent Evidence on the Prevention and Early Treatment of Invasive Fungal Infections in Nonneutropenic Critically Ill Patients?

What Is the Most Recent Evidence on the Prevention and Early Treatment of Invasive Fungal Infections in Nonneutropenic Critically Ill Patients?

Andrea Cortegiani,
Vincenzo Russotto,
Pasquale Iozzo,
Santi Maurio Raineri,
Antonino Giarratano

Cortegiani A, Russotto V, Iozzo P, Raineri SM, Giarratano A. What Is the Most Recent Evidence on the Prevention and Early Treatment of Invasive Fungal Infections in Nonneutropenic Critically Ill Patients?. Arch Clin Infect Dis. 2017;12(4):e12414. doi: https://doi.org/10.5812/archcid.12414

20
Jun
2016
Liposomes in Cosmetics

Liposomes in Cosmetics

Hamid Reza Ahmadi Ashtiani,
Parisa Bishe,
Naser-Aldin Lashgari,
Mohammad Ali Nilforoushzadeh,
Sona Zare

Ahmadi Ashtiani HR, Bishe P, Lashgari N, Nilforoushzadeh MA, Zare S. Liposomes in Cosmetics. J Skin Stem Cell. 2016;3(3):e65815. doi: https://doi.org/10.5812/jssc.65815

More by these authors

Amandeep -PubMedScholar
Shailendra BhattPubMedScholar
Manish KumarPubMedScholar
Sheetal DeviPubMedScholar
Prabhat Kumar UpadhyayPubMedScholar
Vipin SainiPubMedScholar
Amit MittalPubMedScholar
Navneet MehanPubMedScholar
Anupam SainiPubMedScholar
Share
Cited by
Metrics